PE20070332A1 - Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas - Google Patents

Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas

Info

Publication number
PE20070332A1
PE20070332A1 PE2006001056A PE2006001056A PE20070332A1 PE 20070332 A1 PE20070332 A1 PE 20070332A1 PE 2006001056 A PE2006001056 A PE 2006001056A PE 2006001056 A PE2006001056 A PE 2006001056A PE 20070332 A1 PE20070332 A1 PE 20070332A1
Authority
PE
Peru
Prior art keywords
alkyl
heteroaryl
inhibitors
alkylen
phenyl
Prior art date
Application number
PE2006001056A
Other languages
English (en)
Inventor
Alvaro Isabel Castellope
Lopez Jose-Miguel Coteron
Velando Esther Pilar Fernandez
Roman Jose Maria Fiandor
De Francisco Esther Porras
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20070332A1 publication Critical patent/PE20070332A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A COMPUESTOS HETEROARIL-NITRILOS SUSTITUIDOS DE FORMULA (I) EN DONDE R4 ES HALOGENO; R2 ES FENIL-ALQUILEN(C1-C3)-X, PIRIDIL-FENIL-ALQUILEN(C1-C3)-X O FENIL-ALQUILEN(C1-C3)-X-RJ; RJ ES Z -ALQUILEN(C1-C3)-Z O -C(O)Z; X E Y SON INDEPENDIENTEMENTE UN GRUPO HIDROCARBONADO SATURADO MONOCICLICO DE 6 MIEMBROS QUE CONTIENE 1 A 2 ATOMOS DE NITROGENO Y OPCIONALMENTE UN OXIGENO OPCIONALMENTE SUSTITUIDOS CON ALQUILO(C1-C4), OH, ALQUIL(C1-C4)OH, ENTRE OTROS. SON PREFERIDOS: N'-(5-BROMO-2-CIANO-4-PIRIMIDINIL)-N'-(CICLOPENTILMETIL)-4-[(4-METIL-1-PIPERAZINIL)METIL]BENZOHIDRAZIDA, N'-(5-BROMO-2-CIANO-4-PIRIMIDINIL)-N'-(CICLOPENTILMETIL)-4-[(4-HIDROXI-1-PIPERIDINIL)METIL]BENZOHIDRAZIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE CISTEINA PROTEASA HALLADAS EN EL PARASITO DEL PALUDISMO PLASMODIUM FALCIPARUM POR LO QUE SON UTILES EN EL TRATAMIENTO DE MALARIA
PE2006001056A 2005-09-02 2006-08-31 Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas PE20070332A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05381043 2005-09-02
EP06110666 2006-03-03

Publications (1)

Publication Number Publication Date
PE20070332A1 true PE20070332A1 (es) 2007-05-11

Family

ID=37770277

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2006001056A PE20070332A1 (es) 2005-09-02 2006-08-31 Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas
PE2006001057A PE20070612A1 (es) 2005-09-02 2006-08-31 Nuevos inhibidores de cisteina proteasas

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2006001057A PE20070612A1 (es) 2005-09-02 2006-08-31 Nuevos inhibidores de cisteina proteasas

Country Status (4)

Country Link
AR (2) AR057110A1 (es)
PE (2) PE20070332A1 (es)
TW (2) TW200804351A (es)
WO (3) WO2007025776A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2030621A1 (en) * 2007-08-21 2009-03-04 Glaxo Group Limited Novel substituted pyrimidines as cysteine protease inhibitors
WO2008052934A1 (en) * 2006-10-30 2008-05-08 Glaxo Group Limited Novel substituted pyrimidines as cysteine protease inhibitors
EP2168600A1 (en) 2007-06-08 2010-03-31 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for cerebral aneurysm
US20100331545A1 (en) 2007-10-24 2010-12-30 Nippon Chemiphar Co., Ltd. Regulator for signaling toll-like receptor, which comprises cathepsin inhibitor as active ingredient
DE102008063561A1 (de) * 2008-12-18 2010-08-19 Bayer Cropscience Ag Hydrazide, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Insektizide
CN102267964B (zh) * 2011-06-15 2014-06-18 浙江师范大学 3-羟基-2,3-二氢苯并呋喃衍生物及其合成方法和应用
JP7271566B2 (ja) * 2018-03-28 2023-05-11 ハンリム ファーマシューティカル カンパニー リミテッド ２－シアノピリミジン－４－イル カルバメート誘導体もしくはウレア誘導体またはその塩及びそれを含む医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos

Also Published As

Publication number Publication date
AR055624A1 (es) 2007-08-29
WO2007025774A3 (en) 2007-04-26
WO2007025776A2 (en) 2007-03-08
AR057110A1 (es) 2007-11-14
TW200804351A (en) 2008-01-16
TW200804352A (en) 2008-01-16
PE20070612A1 (es) 2007-06-23
WO2007025775A2 (en) 2007-03-08
WO2007025774A2 (en) 2007-03-08
WO2007025776A3 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
PE20070332A1 (es) Compuestos heteroaril-nitrilos sustituidos como inhibidores de cisteina proteasas
PE20081471A1 (es) Derivados de heteroarilnitrilo como inhibidores de cisteina proteasa
ATE427932T1 (de) 11beta-hsd1-inhibitoren
CO5690568A2 (es) Agonismo del receptor de 5ht2a para el tratamiento de disfun cion termorreguladora
UY29246A1 (es) Nuevos compuestos
UY28897A1 (es) Ácido 2-((2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil)amino)-3-(fenilpiridin-2-ilamino)propiónico sustancialmente puro como inhibidor de la cinasa ikb
PE20071223A1 (es) Procedimiento de preparacion de derivados de acil-amino-alquilen-amida
PE20061332A1 (es) Derivados de piperidina como agentes inhibidores de la renina
UY29016A1 (es) Analogos de dipeptidos inhibidores de la hepatitis c
PE20070541A1 (es) Compuestos y composiciones que comprenden isoindol-imidas
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
AR092774A1 (es) Composicion de limpieza que comprende variantes de amilasa con alta estabilidad en la presencia de un agente quelante
PE20070593A1 (es) Compuestos pirrolopirimidina como inhibidores de syk
CO6160301A2 (es) Preparacion solida que contiene alogliptina y clorhidrato de metformina
UY28821A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos.
PE20121157A1 (es) Compuestos heterociclicos como inhibidores de proteasas serinas
UY29169A1 (es) Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica
AR054790A1 (es) Metodos para el tratamiento de disfuncion sexual
ES2421447T3 (es) Métodos para proteger frente a apoptosis usando lipopéptidos
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
PE20080843A1 (es) Inhibidores de renina y metodo para su utilizacion
CR10165A (es) "uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento de depresión"
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
AR077138A1 (es) Composiciones farmaceuticas utiles para tratar el vhc
AR077139A1 (es) Composiciones farmaceuticas utiles para tratar el vch

Legal Events

Date Code Title Description
FD Application declared void or lapsed